Heart failure drugs may increase fall risk in seniors, WHO data suggests
NCT ID NCT07150754
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at reports from the WHO global safety database to see if common heart failure medications are linked to falls in people aged 65 and older. Researchers analyzed over 100,000 records to find which drugs were most often associated with fall reports. The goal is to help doctors prescribe safer treatments for older adults with heart failure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
heart failure pharmacological treatments (drugs like beta-blockers, ACE inhibitors, diuretics)
What this could lead to
If this study finds a clear link between certain heart failure drugs and falls, it could help doctors choose safer medications for older patients.
What could go wrong
This is an observational analysis of existing reports, not a controlled trial. It can show associations but cannot prove cause and effect. Results may not apply to all older adults.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Caen University Hospital, Department of Pharmacology
Caen, Normandy, 14000, France